CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
TATFAR progress report 2016-2020
-
September 2021
[PDF-3.69 MB]
Details:
-
Alternative Title:Transatlantic Taskforce on Antimicrobial Resistance progress report 2016-2020
-
Corporate Authors:
-
Description:AMR is one of the most serious global public health threats. The TATFAR partners—technical experts from government agencies in Canada, the European Union (EU), Norway, and the United States (U.S.)—are committed to the One Health approach to combat AMR by collaborating on activities to improve appropriate antimicrobial use in human health care, veterinary medicine, food animal production and plant protection, prevent antimicrobial- resistant infections, and strengthen the antimicrobial, alternatives, vaccines, and diagnostic pipeline. This report summarizes the progress and outcomes of each action during TATFAR’s last implementation period (2016-2020), as well as plans for continued work for the next five-year work plan (2021-2026).
Although AMR is not a new phenomenon, the current magnitude of the problem and the speed with which new resistance phenotypes and mechanisms have emerged and spread elevates its public health significance.
Produced by the U.S. Centers for Disease Control and Prevention as Secretariat for the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR).
CS325512-A
2021-progress-report-508.pdf?ACSTrackingID=USCDC_426-DM65395&ACSTrackingLabel=%20%20International%20taskforce%20releases%20new%20five-year%20antimicrobial%20resistance%20work%20plan&deliveryName=USCDC_426-DM65395
-
Content Notes:Disclaimer -- Table of Contents -- Acronyms -- Foreword -- Introduction -- TATFAR History and Overall Progress -- KEY AREA 1: Appropriate therapeutic use in human and veterinary medicine -- KEY AREA 2: Prevention of drug-resistant infections -- KEY AREA 3: Strategies for improving the pipeline of new antimicrobial drugs -- Conclusion.
-
Subjects:
-
Document Type:
-
Pages in Document:46 numbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
